The active component of the marijuana plant, cannabinoids, have shown to inhibit tumor growth and kill cancer cells in lab testings. We work with a number of patients who use cannabis to treat their cancer and suppress it's side effects.
Medical marijuana contains antispasmodic qualities which relax muscles and has shown to be an effective treatment for seizures. Marijuana oils that are rich in cannabidol (CBD), are the preferred method for treatment.
Patients who suffer from chronic pain caused by diabetes, cancer, MS, HIV, and other diseases have been turning to medical marijuana as a way to treat their pain without the use of addictive pharmaceutical medications.
We are proud to announce that Seven Leaf magazine is now a subscription based magazine. We are expanding thanks to our loyal reader ship. Seven Leaf magazine will now be distributed to: Las Vegas, California, Oregon and Arizona to start. Subscriptions are available throughout the United States and Canada.
What you will find in seven Leaf magazine: Cannabis locations, CBD, Entertainment, Growers, Real Estate, Medical Break through's, / survivor stories and Cannabis events.
Seven Leaf can and will be found in all Dispensaries throughout the states mentioned above, Including medical offices and soon to Barnes & Noble throughout the United States.
TO SUBSCRIBE, SIMPLY CLICK ON THE SUBSCRIBE TODAY BUTTON BELOW TO BEGIN YOUR ENJOYMENT OF SEVEN LEAF MAGAZINE
The Drug Enforcement Administration (DEA) isn’t exactly known as big fan of marijuana. But in a new Federal Register filing set to be published soon, the anti-drug agency is moving to more than quintuple the amount of cannabis that can legally be grown in the U.S. for research purposes—from roughly 1,000 pounds in 2018 to more than 5,400 pounds next year.
At the same time, DEA is also pushing to reduce the amount of certain opioid drugs—such as oxycodone, hydrocodone, morphine, fentanyl and others—that are produced in the U.S.
“We’ve lost too many lives to the opioid epidemic and families and communities suffer tragic consequences every day,” DEA Acting Administrator Uttam Dhillon said in a press release. “This significant drop in prescriptions by doctors and DEA’s production quota adjustment will continue to reduce the amount of drugs available for illicit diversion and abuse while ensuring that patients will continue to have access to proper medicine.”
U.S. Attorney General Jeff Sessions, a longtime opponent of marijuana legalization, added that “the opioid epidemic that we are facing today is the worst drug crisis in American history… Cutting opioid production quotas by an average of ten percent next year will help us continue that progress and make it harder to divert these drugs for abuse.”
The proposed quotas for cannabis and other drugs “reflects the total amount of controlled substances necessary to meet the country’s medical, scientific, research, industrial, and export needs for the year and for the establishment and maintenance of reserve stocks,” DEA said.
The 2,450,000 grams of marijuana the narcotics agency wants grown in the country in 2019 is a significant bump up from the 443,680 grams the agency authorized for 2018.